PUBLICACIÓN

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: The potential value of the PEPs study

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Mas S.; Llerena A.; Saiz J.; Bernardo M.; Lafuente A.

2012 PHARMACOGENOMICS

Genetics (Q3), Molecular Medicine (Q2), Pharmacology (Q2)

JCR: 3.857

SJR: 0.968


CITAS

16

DOI

10.2217/pgs.12.159

EID

2-s2.0-84869995013

ISSN

1462-2416

EISSN

1744-8042

BIBTEX

@article { author = {Mas S and Llerena A and Saíz J and Bernardo M and Lafuente A}, title = {Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study.}, year = {2012}, month = {nov}, url = {http://europepmc.org/abstract/med/23171340}, doi = {10.2217/pgs.12.159} }


AUTORES DE LA UEX